Cargando…
Role of SH3GLB1 in the regulation of CD133 expression in GBM cells
BACKGROUND: Glioblastoma (GBM), a malignant brain tumor, has poor survival outcomes due to recurrence or drug resistance. We found that SH3GLB1 is a crucial factor for cells to evade temozolomide (TMZ) cytotoxicity through autophagy-mediated oxidative phosphorylation, which is associated with CD133...
Autores principales: | Chien, Chia-Hung, Lai, Chien-Cheng, Chuang, Jian-Ying, Chu, Jui-Mei, Liu, Chan-Chuan, Chang, Kwang-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391956/ https://www.ncbi.nlm.nih.gov/pubmed/37525108 http://dx.doi.org/10.1186/s12885-023-11211-8 |
Ejemplares similares
-
SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma
por: Chien, Chia-Hung, et al.
Publicado: (2022) -
SH3GLB2/endophilin B2 regulates lung homeostasis and recovery from severe influenza A virus infection
por: Fino, Kristin K., et al.
Publicado: (2017) -
Population analysis of the GLB1 gene in South Brazil
por: Baiotto, Cléia, et al.
Publicado: (2011) -
CD133/prominin1 is prognostic for GBM patient’s survival, but inversely correlated with cysteine cathepsins’ expression in glioblastoma derived spheroids
por: Ardebili, Seyed Y., et al.
Publicado: (2011) -
Response to Stress in Early Tumor Colonization Modulates Switching of CD133-Positive and CD133-Negative Subpopulations in a Human Metastatic Colon Cancer Cell Line, SW620
por: Hsu, Chih-Sin, et al.
Publicado: (2013)